stella
beta
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease — Stella
Home
/
Lymphoma, Primary Effusion
/
View on ClinicalTrials.gov
Recruiting
Back to Lymphoma, Primary Effusion trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
National Institutes of Health Clinical Center, Bethesda, Maryland